Zobrazeno 1 - 8
of 8
pro vyhledávání: '"PIRNAT, D"'
Publikováno v:
Annals of the New York Academy of Sciences. 1009
Imidazoline receptor agonists such as moxonidine and rilmenidine increase sodium excretion whether administered within the central nervous system, intravenously, or directly into the renal artery. To determine if this natriuresis was mediated by a di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a99523a77143923e4ac45603631e37
https://pubmed.ncbi.nlm.nih.gov/15028602
https://pubmed.ncbi.nlm.nih.gov/15028602
Publikováno v:
Annals of the New York Academy of Sciences; 2004, Vol. 1009 Issue 1, p288-295, 8p
Publikováno v:
Annals of the New York Academy of Sciences; December 2003, Vol. 1009 Issue: 1 p288-295, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pirnat, Deni
In our preliminary dose--response study two I1 -imidazoline receptor agonists (rilmenidine and moxonidine) and two _ 2-adrenoceptor agonists (clonidine and guanfacine) were investigated. Based on those studies, we selected rilmenidine (10 nmol/kg/min
Externí odkaz:
http://hdl.handle.net/1993/2750
Autor:
Pirnat, Deni
In our preliminary dose--response study two I1 -imidazoline receptor agonists (rilmenidine and moxonidine) and two _ 2-adrenoceptor agonists (clonidine and guanfacine) were investigated. Based on those studies, we selected rilmenidine (10 nmol/kg/min
Externí odkaz:
http://hdl.handle.net/1993/2750
Autor:
Pirnat, Deni
In our preliminary dose--response study two I1 -imidazoline receptor agonists (rilmenidine and moxonidine) and two _ 2-adrenoceptor agonists (clonidine and guanfacine) were investigated. Based on those studies, we selected rilmenidine (10 nmol/kg/min
Externí odkaz:
http://hdl.handle.net/1993/2750